Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Patient Safety Continuing appetite-suppressing medication at very low BMIs may increase the risk of: Excessive or unintended weight loss Nutritional deficiencies Lean muscle loss Hormonal disruption Disordered eating patterns The BMI 22 kg/m threshold acts as a safety boundary
Together, these functions can help you feel less hungry, causing you to eat less food and lose more weight
Using the Savings Offer
The constipation typically appears within the first few weeks of starting semaglutide and often improves as your body adjusts
US$ 26.88
US$ 21.25
US$ 27.27
US$ 22.81
